Correlation Between BioNTech and Novavax

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioNTech and Novavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Novavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and Novavax, you can compare the effects of market volatilities on BioNTech and Novavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Novavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Novavax.

Diversification Opportunities for BioNTech and Novavax

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between BioNTech and Novavax is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Novavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novavax and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Novavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novavax has no effect on the direction of BioNTech i.e., BioNTech and Novavax go up and down completely randomly.

Pair Corralation between BioNTech and Novavax

Given the investment horizon of 90 days BioNTech SE is expected to generate 0.76 times more return on investment than Novavax. However, BioNTech SE is 1.31 times less risky than Novavax. It trades about -0.11 of its potential returns per unit of risk. Novavax is currently generating about -0.25 per unit of risk. If you would invest  11,088  in BioNTech SE on August 23, 2024 and sell it today you would lose (874.00) from holding BioNTech SE or give up 7.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BioNTech SE  vs.  Novavax

 Performance 
       Timeline  
BioNTech SE 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BioNTech showed solid returns over the last few months and may actually be approaching a breakup point.
Novavax 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novavax has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

BioNTech and Novavax Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioNTech and Novavax

The main advantage of trading using opposite BioNTech and Novavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Novavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novavax will offset losses from the drop in Novavax's long position.
The idea behind BioNTech SE and Novavax pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges